» Articles » PMID: 25693108

Nalbuphine, a Non-controlled Opioid Analgesic, and Its Potential Use in Research Mice

Overview
Journal Lab Anim (NY)
Date 2015 Feb 19
PMID 25693108
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Nalbuphine is an inexpensive, non-controlled, opioid analgesic that has been in clinical use for decades. A kappa opioid receptor agonist and mu opioid receptor antagonist, nalbuphine causes fewer adverse effects than other opioid analgesics. The author reviews the characteristics of nalbuphine, analyzes studies of nalbuphine in mice and explores the potential use of nalbuphine to treat pain in research mice. In analgesiometric studies in mice, nalbuphine ameliorates both somatic and visceral pain. Nalbuphine seems to have a broad range of safe doses for subcutaneous administration in mice. Unlike non-steroidal anti-inflammatory drugs, nalbuphine does not antagonize prostaglandins or impede labor in mice. Although additional study is needed before clinical use can be recommended, evidence presented here suggests that nalbuphine might be an effective analgesic for dystocia (or difficult birth) and other painful conditions in research mice.

Citing Articles

Nalbuphine May Be Superior to Sufentanil in Relieving Postcesarean Uterine Contraction Pain in Multiparas: A Retrospective Cohort Study.

Zheng K, Chen B, Sun J Drug Des Devel Ther. 2023; 17:1405-1415.

PMID: 37188281 PMC: 10178296. DOI: 10.2147/DDDT.S394664.


Analgesic Effects and Safety of Dexmedetomidine Added to Nalbuphine or Sufentanil Patient-Controlled Intravenous Analgesia for Children After Tonsillectomy Adenoidectomy.

Jia Y, Zhou R, Li Z, Wang Y, Chen S, Zhao L Front Pharmacol. 2022; 13:908212.

PMID: 35600878 PMC: 9117536. DOI: 10.3389/fphar.2022.908212.


Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice.

Santos E, Banks M, Negus S J Pharmacol Exp Ther. 2022; 382(1):44-53.

PMID: 35489781 PMC: 9341253. DOI: 10.1124/jpet.121.001045.


A Dose-Response Relationship Study of Prophylactic Nalbuphine to Reduce Pain During the Awakening Period in Patients Undergoing Laparoscopic Total Hysterectomy: A Randomized, Controlled, Double-Blind Clinical Study.

Wang M, Wang D, Zuo J, Liu T, Niu Z, Xie J Drug Des Devel Ther. 2022; 16:981-990.

PMID: 35386854 PMC: 8979566. DOI: 10.2147/DDDT.S356582.


Pain management after ambulatory surgery: a prospective, multicenter, randomized, double-blinded parallel controlled trial comparing nalbuphine and tramadol.

Guan Y, Wei L, Liao Q, Fang Q, He N, Han C BMC Anesthesiol. 2020; 20(1):204.

PMID: 32799814 PMC: 7429784. DOI: 10.1186/s12871-020-01125-4.


References
1.
. Laboratory animal welfare; U.S. government principles for the utilization and care of vertebrate animals used in testing, research and training; notice. Fed Regist. 1985; 50(97):20864-5. View

2.
Winchester S, Imamura T, Gross G, Muglia L, Vogt S, Wright J . Coordinate regulation of prostaglandin metabolism for induction of parturition in mice. Endocrinology. 2002; 143(7):2593-8. DOI: 10.1210/endo.143.7.8926. View

3.
Coetzee J, Lechtenberg K, Stock M, KuKanich B . Pharmacokinetics and effect of intravenous nalbuphine in weaned Holstein calves after surgical castration. J Vet Pharmacol Ther. 2013; 37(2):169-77. DOI: 10.1111/jvp.12077. View

4.
Liu Y, Malik N, Sanger G, Friedman M, Andrews P . Pica--a model of nausea? Species differences in response to cisplatin. Physiol Behav. 2005; 85(3):271-7. DOI: 10.1016/j.physbeh.2005.04.009. View

5.
Woollard M, Whitfield R, Smith K, Jones T, Thomas G, Hinton C . Less IS less: a randomised controlled trial comparing cautious and rapid nalbuphine dosing regimens. Emerg Med J. 2004; 21(3):362-4. PMC: 1726344. DOI: 10.1136/emj.2004.014324. View